ArticlePloS one2026

Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells.

Alena Mrkvicova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.